Keros Therapeutics
KROS
#6734
Rank
ยฃ0.48 B
Marketcap
ยฃ15.99
Share price
-1.71%
Change (1 day)
-69.64%
Change (1 year)

Keros Therapeutics (KROS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ29.4 Million

According to Keros Therapeutics's latest financial reports the company's total liabilities are ยฃ29.4 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Keros Therapeutics - Total liabilities on balance sheet (from 2019 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ35.32 M19.03%
2023-12-31ยฃ29.67 M22.31%
2022-12-31ยฃ24.26 M171.23%
2021-12-31ยฃ8.94 M57.93%
2020-12-31ยฃ5.66 M-28.98%
2019-12-31ยฃ7.97 M-30.9%
2018-12-31ยฃ11.54 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
ยฃ18.2 M-38.08%๐Ÿ‡บ๐Ÿ‡ธ USA